85248-201

Manufacturer
Jiangxi Yudexi Pharmaceutical Co., LTD | Jiangxi Zhongletang Pharmaceuticals Co.,Ltd.
Effective date
2026-04-30
Label type
HUMAN OTC DRUG LABEL
Version
1
Source
full-release
Hydrated at
2026-06-01 01:55:54

Label at a glance#

ProductMINADCIN WART REMOVER PATCHES
Active ingredientSALICYLIC ACID
Label structure13 sections

Dosage and administration

wash affected area: may soak wart in warm water for 5 minutes dry area thoroughly,remove bandage strips by peeling backing off.If necessary,cut medicated patch to fit wart carefully apply medicated plaster, repeat procedure every 48 hours as needed (until wart is removed) for up to 12 week

Storage and handling

Store between 59° and 86°F(15°and 30°C).

Label contents#

Full prescribing information#

Active Ingredient

OTC - ACTIVE INGREDIENT SECTION

Salicylic acid 17%

Purpose

OTC - PURPOSE SECTION

Wart Remover

Use

INDICATIONS & USAGE SECTION

For the removal of common warts. The common wart is easily recognized by the rough 'cauliflower-like' appearance of the surface

Warnings

WARNINGS SECTION

For external use only.

Do not use

OTC - DO NOT USE SECTION

On irritated,infected, or reddened skin; on genital warts and warts on the face; on moles, birthmarks, and warts with hair growing from them;on mucous membranes.

When Using

OTC - WHEN USING SECTION

Ask a doctor before use if you have diabetes, poor blood circulation

Stop Use

OTC - STOP USE SECTION

Ask a doctor before use if you have diabetes, poor blood circulation

Ask Doctor

OTC - ASK DOCTOR SECTION

Ask a doctor before use if you have diabetes, poor blood circulation

Keep Out Of Reach Of Children

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

If swallowed, get medical help or contact a Poison Control Center right away.

Directions

DOSAGE & ADMINISTRATION SECTION

wash affected area: may soak wart in warm water for 5 minutes dry area thoroughly,remove bandage strips by peeling backing off.If necessary,cut medicated patch to fit wart carefully apply medicated plaster, repeat procedure every 48 hours as needed (until wart is removed) for up to 12 week

Other information

STORAGE AND HANDLING SECTION

Store between 59° and 86°F(15°and 30°C).

Inactive ingredients

INACTIVE INGREDIENT SECTION

hard paraffin,lanolin,phenol.

PRINCIPAL DISPLAY PANEL

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

1717

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYSPL version
2722666salicylic acid 17 % Medicated PatchPSN1
2722666salicylic acid 0.17 MG/MG Medicated PatchSCD1
2722666salicylic acid 17 % Medicated PatchSY1

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
85248-201-01MINADCIN WART REMOVER PATCHES144 in 1 BOXPATCH1441

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 6 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
85248-20185248-201-01

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 4 matching rows.

Name, UNII, Kind table
NameUNIIKind
SALICYLIC ACIDO414PZ4LPZACTIB
PARAFFINI9O0E3H2ZEIACT
LANOLIN7EV65EAW6HIACT
PHENOL339NCG44TVIACT

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
MINADCIN WART REMOVER PATCHESSALICYLIC ACID 17% WART REMOVERJiangxi Yudexi Pharmaceutical Co., LTD50aaae3a-26b3-49e5-e063-6394a90ae5fc2026-04-30WarningsExact identifier
ndc (package): 85248-201-01
ndc (product): 85248-201
ndc11 (package): 85248020101
spl id: 50aaae3a-26b4-49e5-e063-6394a90ae5fc
spl set id: 50aaae3a-26b3-49e5-e063-6394a90ae5fc

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.